These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Time to Peak International Normalized Ratio Rise in Acute and Acute-on-Chronic Warfarin Overdoses. Minhaj FS; Leonard JB; Seung H; Klein-Schwartz W J Cardiovasc Pharmacol; 2021 Sep; 78(3):474-479. PubMed ID: 34516454 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases. Denas G; Marzot F; Offelli P; Stendardo A; Cucchini U; Russo R; Nante G; Iliceto S; Pengo V J Thromb Thrombolysis; 2009 Apr; 27(3):340-7. PubMed ID: 18338109 [TBL] [Abstract][Full Text] [Related]
6. Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study. Limdi NA; Nolin TD; Booth SL; Centi A; Marques MB; Crowley MR; Allon M; Beasley TM Am J Kidney Dis; 2015 May; 65(5):701-9. PubMed ID: 25468385 [TBL] [Abstract][Full Text] [Related]
7. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa. Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317 [TBL] [Abstract][Full Text] [Related]
8. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10. Gunther KE; Conway G; Leibach L; Crowther MA Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584 [TBL] [Abstract][Full Text] [Related]
9. The use of vitamin K in patients on anticoagulant therapy: a practical guide. Hanslik T; Prinseau J Am J Cardiovasc Drugs; 2004; 4(1):43-55. PubMed ID: 14967065 [TBL] [Abstract][Full Text] [Related]
10. Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10. Farrow GS; Delate T; McNeil K; Jones AE; Witt DM; Crowther MA; Clark NP J Thromb Haemost; 2020 May; 18(5):1133-1140. PubMed ID: 32073738 [TBL] [Abstract][Full Text] [Related]
11. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial. Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768 [TBL] [Abstract][Full Text] [Related]
12. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy. Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834 [TBL] [Abstract][Full Text] [Related]
13. Evaluating warfarin management by pharmacists in a community teaching hospital. Chilipko AA; Norwood DK Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419 [TBL] [Abstract][Full Text] [Related]
14. Supratherapeutic international normalized ratio due to reduced vitamin K intake secondary to prolonged vomiting in a patient on warfarin. Reaves AB; Clarke CJ; Tillman EM Ann Pharmacother; 2013 Jun; 47(6):e28. PubMed ID: 23719786 [TBL] [Abstract][Full Text] [Related]
15. [Bleeding risk and perioperative management of patients anticoagulated with vitamin K antagnosists]. Angelo M; Stockner I; Wiedermann CJ Wien Med Wochenschr; 2008; 158(21-22):615-20. PubMed ID: 19052707 [TBL] [Abstract][Full Text] [Related]
16. Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer. Lee R; Wen A; Berube C Am J Health Syst Pharm; 2011 May; 68(9):814-7. PubMed ID: 21515865 [TBL] [Abstract][Full Text] [Related]
17. Acetaminophen and other risk factors for excessive warfarin anticoagulation. Hylek EM; Heiman H; Skates SJ; Sheehan MA; Singer DE JAMA; 1998 Mar; 279(9):657-62. PubMed ID: 9496982 [TBL] [Abstract][Full Text] [Related]